Does TOFACITINIB Cause Lower respiratory tract infection? 3,121 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 3,121 reports of Lower respiratory tract infection have been filed in association with TOFACITINIB (XELJANZ XR). This represents 2.0% of all adverse event reports for TOFACITINIB.
3,121
Reports of Lower respiratory tract infection with TOFACITINIB
2.0%
of all TOFACITINIB reports
1,127
Deaths
1,710
Hospitalizations
How Dangerous Is Lower respiratory tract infection From TOFACITINIB?
Of the 3,121 reports, 1,127 (36.1%) resulted in death, 1,710 (54.8%) required hospitalization, and 1,325 (42.5%) were considered life-threatening.
Is Lower respiratory tract infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 3,121 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Lower respiratory tract infection?
METHOTREXATE (6,049)
GOLIMUMAB (5,660)
ETANERCEPT (5,546)
CERTOLIZUMAB PEGOL (5,137)
TOCILIZUMAB (4,973)
ABATACEPT (4,947)
LEFLUNOMIDE (4,580)
ADALIMUMAB (4,109)
RITUXIMAB (4,041)
ACETAMINOPHEN (3,996)
Which TOFACITINIB Alternatives Have Lower Lower respiratory tract infection Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN